We further show that impairment of Smo signaling alters the phosphorylation state of KCC2, thus maintaining a depolarizing action of GABA, which leads to an alteration of GABAergic inhibitory transmission and might contribute to the emergence of brain disorders. This evidence concerns the gene SMO and brain disorder.